record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundexperimental · manual state transition; control details require source inspection · Homo sapiens
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition; control details require source inspection
evidence type
experimental
species
Homo sapiens
evidence spans
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model. — Lecanemab is a humanized IgG1 monoclonal antibody binding with high affinity to protofibrils of amyloid-beta (Aβ) protein. In clinical studies, lecanemab...
Bhagunde P; Penner N; Willis BA; Bell R; Charil A; Irizarry MC. CPT: pharmacometrics & systems pharmacology 2026. doi:10.1002/psp4.70173 · curator_source · 10.1002/psp4.70173
conditions
Provenance
source title
Bhagunde P; Penner N; Willis BA; Bell R; Charil A; Irizarry MC. CPT: pharmacometrics & systems pharmacology 2026. doi:10.1002/psp4.70173
doi
10.1002/psp4.70173
journal
CPT: pharmacometrics & systems pharmacology
authors
Bhagunde P, Penner N, Willis BA, Bell R, Charil A, Irizarry MC
Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model. — Lecanemab is a humanized IgG1 monoclonal antibody binding with high affinity to protofibrils of amyloid-beta (Aβ) protein. In clinical studies, lecanemab...
vs_82e15644021eb7f5 · source:Bhagunde P; Penner N; Willis BA; Bell R; Charil A; Irizarry MC. CPT: pharmacometrics & systems pharmacology 2026. doi:10.1002/psp4.70173|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_789844873d74f513finding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_f64b0986f3496c6dfinding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.